The role of ifosfamide in paediatric cancer

Australian and New Zealand Journal of Medicine

Volumn 28, Issue 3, 1998, Pages 410-413

  Advani, S H ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Chemotherapy; Ewings' sarcoma; Ifosfamide; Paediatric tumours; Soft tissue sarcoma; Wilms' tumour

Indexed keywords

IFOSFAMIDE;

BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; CONFERENCE PAPER; DRUG EFFICACY; EWING SARCOMA; HEMORRHAGIC CYSTITIS; HUMAN; MALE INFERTILITY; NEUROBLASTOMA; NEUTROPENIA; RHABDOMYOSARCOMA;

EID: 0031878067     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1998.tb01976.x     Document Type: Conference Paper

References (4)

1. Voute PA, Van den Berg H, Behrendt H, Michiels E, Kraker J De. Ifosfamide in the treatment of pediatric malignancies. Semin Oncol 1996; 23: 8-11.
2. Magrath I. Malignant non Hodgkins lymphoma in children. In: Pizzo PA, Poplack DG. (Eds). Principles and practice of pediatric oncology. Philadelphia: JB Lippincott, 1992.
3. Otten J, Flamant F, Rodary C et al. Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide+vincristine+ dactinomycin (IVA) as front line therapy (a SIOP study). Cancer Chemother Pharmacol 1989; 24: S30 (Suppl. 1).
4. Castleberry RP, Cantoor AB, Green AA et al. Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastomas: A pediatric Oncology Study Group. J Clin Oncol 1994; 12: 1616-20.